Stock data
Bioventus Inc. (BVS)
Bioventus Inc. (BVS) reported revenue of US$568.09M and net income of US$22.73M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$568.09M | US$388.16M | US$53.98M | US$22.73M | — |
| 2024 | US$573.28M | US$388.23M | -US$15.20M | -US$36.12M | — |
| 2023 | US$512.35M | US$328.19M | -US$81.72M | -US$156.23M | — |
| 2022 | US$512.12M | US$331.08M | -US$167.23M | -US$158.70M | — |
| 2021 | US$430.90M | US$302.71M | US$12.06M | US$19.38M | — |
Quarterly results
Data as of 2026-06-27
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-27 | US$153.21M | US$33.44M | — |
| 2026-03-28 | US$132.09M | US$3.11M | — |
| 2025-12-31 | US$157.90M | US$14.76M | — |
| 2025-09-27 | US$138.65M | US$3.15M | — |
| 2025-06-28 | US$147.66M | US$7.46M | — |
| 2025-03-29 | US$123.88M | -US$2.64M | — |
| 2024-12-31 | US$153.64M | -US$0.39M | — |
| 2024-09-28 | US$138.96M | -US$5.17M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.